| PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery D Luong, P Kesharwani, R Deshmukh, MCIM Amin, U Gupta, K Greish, ... Acta biomaterialia 43, 14-29, 2016 | 340 | 2016 |
| Resistance to Checkpoint Inhibition in Cancer Immunotherapy RRD Luisa Barrueto, Francheska Caminero, Lindsay Cash, Courtney Makrisa ... Translational Oncology 13 (3), 100738, 2020 | 218 | 2020 |
| From bortezomib to other inhibitors of the proteasome and beyond D Buac, M Shen, S Schmitt, F Rani Kona, R Deshmukh, Z Zhang, ... Current pharmaceutical design 19 (22), 4025-4038, 2013 | 169 | 2013 |
| Deubiquitinases (DUBs) and DUB inhibitors: a patent review P Farshi, RR Deshmukh, JO Nwankwo, RT Arkwright, B Cvek, J Liu, ... Expert opinion on therapeutic patents 25 (10), 1191-1208, 2015 | 122 | 2015 |
| Pentacyclic triterpenes: New tools to fight metabolic syndrome H Sharma, P Kumar, RR Deshmukh, A Bishayee, S Kumar Phytomedicine 50, 166-177, 2018 | 93 | 2018 |
| Immunotherapies and Combination Strategies for Immuno-Oncology RRD Cody Barbari, Tyler Fontaine, Priyanka Parajuli, Narottam Lamichhane ... Int. J. Mol. Sci. 21 (14), 5009, 2020 | 87 | 2020 |
| Antidiabetic potential of Phyllanthus reticulatus in alloxan-induced diabetic mice VDR S. Kumar, D. Kumar, R. R. Deshmukh, P.D. Lokhande, S.N. More Fitoterapia (2008) 21–23 79 (1), 21-23, 2008 | 84* | 2008 |
| Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9 SR Boston, R Deshmukh, S Strome, UD Priyakumar, AD MacKerell, ... BMC cancer 11, 1-12, 2011 | 62 | 2011 |
| Development of extracellular signal-regulated kinase inhibitors K Burkhard, S Smith, R Deshmukh, AD MacKerell Jr, P Shapiro Current topics in medicinal chemistry 9 (8), 678-689, 2009 | 54 | 2009 |
| Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis L Lu, W Shi, RR Deshmukh, J Long, X Cheng, W Ji, G Zeng, X Chen, ... PLoS One 9 (11), e113783, 2014 | 45 | 2014 |
| The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives RRD Morgan Maiolini,Stacey Gause,Jerika Taylor,Tara Steakin,Ginger Shipp ... Molecules 25 (13), 3011, 2020 | 41 | 2020 |
| Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells SMP Joshua R. Heyza, Sanjeevani Arora, Hao Zhang, Kayla L. Conner, Wen Lei ... Nutrients 10 (11), 1644, 2018 | 37 | 2018 |
| Novel Delivery Systems for Checkpoint Inhibitors NL Purushottam Lamichhane, Rahul Deshmukh, Julie A. Brown, Silvia Jakubski ... Medicines 74 (6(3)), 2019 | 31 | 2019 |
| Colorectal Cancer and Probiotics: Are Bugs Really Drugs? RD Purushottam Lamichhane, Morgan Maiolini, Omar Alnafoosi, Sedra Hussein ... Cancers 12 (5), 1162, 2020 | 27 | 2020 |
| l-Ornithine Schiff base–copper and –cadmium complexes as new proteasome inhibitors and apoptosis inducers in human cancer cells Z Zhang, C Bi, Y Fan, N Zhang, R Deshmukh, X Yan, X Lv, P Zhang, ... JBIC Journal of Biological Inorganic Chemistry 20, 109-121, 2015 | 26 | 2015 |
| P‐glycoprotein inhibition sensitizes human breast cancer cells to proteasome inhibitors RR Deshmukh, S Kim, Y Elghoul, QP Dou Journal of cellular biochemistry 118 (5), 1239-1248, 2017 | 21 | 2017 |
| Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells RR Deshmukh, QP Dou Breast cancer research and treatment 153, 79-88, 2015 | 21 | 2015 |
| Lessons from nature: sources and strategies for developing AMPK activators for cancer chemotherapeutics R T Arkwright, R Deshmukh, N Adapa, R Stevens, E Zonder, Z Zhang, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 12 | 2015 |
| Durvalumab: a newly approved checkpoint inhibitor for the treatment of urothelial carcinoma RD Stephanie Wills, Lana K Hochmuth, Kenneth S Bauer Jr Current Problems in Cancer 43 (3), 181-194, 2019 | 9 | 2019 |
| Avelumab: A Novel Anti-PD-L1 Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma, RRD Amanda Teets, Linda Pham, Thi Tran, Lana Hochmuth Critical Reviews in Immunology 38 (3), 159-206, 2018 | 8 | 2018 |
